PHEN emerged among fierce competition for life science advocacy by being part of the BIO International Convention, held from June 18 – 21 at the Boston Convention and Exhibition Center in Boston, MA. The convention is a global event that brings together different organizations to partner, explore, promote and discuss with more than 1,000 companies and institutions of the Biotechnology Industry Organization (BIO). BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
PHEN took part in the exhibition center, with its mission, resources, and more on display for the thousands of attendees at the convention. While big pharmaceutical companies are the end-players in drug development, patient’s needs are the drivers for drug research, and PHEN established itself as a leader as it advocated and educated specifically for prostate cancer victims across the nation about personal diagnostics, treatments, and clinical trial opportunities.